CRx 102

Known as: CRx-102, CRx102 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2010
0120082010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
OBJECTIVE To evaluate the responsiveness of joint counts, patient-reported measures and proposed composite scores in hand… (More)
Is this relevant?
2009
2009
CRx-102 is an oral synergistic combination drug which contains the cardiovascular agent, dipyridamole (DP) and a very low dose of… (More)
  • figure 2
  • figure 5
  • table 1
Is this relevant?
2009
2009
BACKGROUND Periodontal disease is the most common multifactorial disease, afflicting a very large proportion of the adult… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
We have developed and validated an accurate, sensitive, and robust LC-MS/MS method that determines the concentration of CRx-102… (More)
Is this relevant?
2008
2008
OBJECTIVE The novel synergistic drug candidate CRx-102 comprises dipyridamole and low dose prednisolone and is in clinical… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?